These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 3001730

  • 1. Molecular cloning of the neu gene: absence of gross structural alteration in oncogenic alleles.
    Hung MC, Schechter AL, Chevray PY, Stern DF, Weinberg RA.
    Proc Natl Acad Sci U S A; 1986 Jan; 83(2):261-4. PubMed ID: 3001730
    [Abstract] [Full Text] [Related]

  • 2. The neu gene: an erbB-homologous gene distinct from and unlinked to the gene encoding the EGF receptor.
    Schechter AL, Hung MC, Vaidyanathan L, Weinberg RA, Yang-Feng TL, Francke U, Ullrich A, Coussens L.
    Science; 1985 Sep 06; 229(4717):976-8. PubMed ID: 2992090
    [Abstract] [Full Text] [Related]

  • 3. The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigen.
    Schechter AL, Stern DF, Vaidyanathan L, Decker SJ, Drebin JA, Greene MI, Weinberg RA.
    Nature; 1985 Sep 06; 312(5994):513-6. PubMed ID: 6095109
    [Abstract] [Full Text] [Related]

  • 4. A v-erbB-related protooncogene, c-erbB-2, is distinct from the c-erbB-1/epidermal growth factor-receptor gene and is amplified in a human salivary gland adenocarcinoma.
    Semba K, Kamata N, Toyoshima K, Yamamoto T.
    Proc Natl Acad Sci U S A; 1985 Oct 06; 82(19):6497-501. PubMed ID: 2995967
    [Abstract] [Full Text] [Related]

  • 5. Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185.
    Bargmann CI, Hung MC, Weinberg RA.
    Cell; 1986 Jun 06; 45(5):649-57. PubMed ID: 2871941
    [Abstract] [Full Text] [Related]

  • 6. Phosphorylation process induced by epidermal growth factor alters the oncogenic and cellular neu (NGL) gene products.
    Kokai Y, Dobashi K, Weiner DB, Myers JN, Nowell PC, Greene MI.
    Proc Natl Acad Sci U S A; 1988 Aug 06; 85(15):5389-93. PubMed ID: 2899889
    [Abstract] [Full Text] [Related]

  • 7. Amplification of the proto-neu oncogene facilitates oncogenic activation by a single point mutation.
    Hung MC, Yan DH, Zhao XY.
    Proc Natl Acad Sci U S A; 1989 Apr 06; 86(8):2545-8. PubMed ID: 2565034
    [Abstract] [Full Text] [Related]

  • 8. The role of non-ras transforming genes in chemical carcinogenesis.
    Cooper CS.
    Environ Health Perspect; 1991 Jun 06; 93():33-40. PubMed ID: 1685444
    [Abstract] [Full Text] [Related]

  • 9. The neu oncogene encodes an epidermal growth factor receptor-related protein.
    Bargmann CI, Hung MC, Weinberg RA.
    Nature; 1991 Jun 06; 319(6050):226-30. PubMed ID: 3945311
    [Abstract] [Full Text] [Related]

  • 10. Cloning and activation of the Syrian hamster neu proto-oncogene.
    Nakamura T, Ushijima T, Ishizaka Y, Nagao M, Arai M, Yamazaki Y, Ishikawa T.
    Gene; 1994 Mar 25; 140(2):251-5. PubMed ID: 7908275
    [Abstract] [Full Text] [Related]

  • 11. Down-modulation of an oncogene protein product and reversion of the transformed phenotype by monoclonal antibodies.
    Drebin JA, Link VC, Stern DF, Weinberg RA, Greene MI.
    Cell; 1985 Jul 25; 41(3):697-706. PubMed ID: 2860972
    [Abstract] [Full Text] [Related]

  • 12. Oncogenic activation of the neu-encoded receptor protein by point mutation and deletion.
    Bargmann CI, Weinberg RA.
    EMBO J; 1988 Jul 25; 7(7):2043-52. PubMed ID: 2901345
    [Abstract] [Full Text] [Related]

  • 13. neu protooncogene fused to an immunoglobulin heavy chain gene requires immunoglobulin light chain for cell surface expression and oncogenic transformation.
    Flanagan JG, Leder P.
    Proc Natl Acad Sci U S A; 1988 Nov 25; 85(21):8057-61. PubMed ID: 2903500
    [Abstract] [Full Text] [Related]

  • 14. Transfected neu oncogene induces human prostate cancer metastasis.
    Zhau HY, Zhou J, Symmans WF, Chen BQ, Chang SM, Sikes RA, Chung LW.
    Prostate; 1996 Feb 25; 28(2):73-83. PubMed ID: 8604395
    [Abstract] [Full Text] [Related]

  • 15. Transformation of NIH 3T3 cells by overexpression of the normal coding sequence of the rat neu gene.
    Di Marco E, Pierce JH, Knicley CL, Di Fiore PP.
    Mol Cell Biol; 1990 Jun 25; 10(6):3247-52. PubMed ID: 1971420
    [Abstract] [Full Text] [Related]

  • 16. Acquisition of a tumorigenic phenotype by a rat ventral prostate epithelial cell line expressing a transfected activated neu oncogene.
    Sikes RA, Chung LW.
    Cancer Res; 1992 Jun 01; 52(11):3174-81. PubMed ID: 1350510
    [Abstract] [Full Text] [Related]

  • 17. Down-regulation of cellular platelet-derived growth factor receptors induced by an activated neu receptor tyrosine kinase.
    Lehtola L, Nistér M, Hölttä E, Westermark B, Alitalo K.
    Cell Regul; 1991 Aug 01; 2(8):651-61. PubMed ID: 1685673
    [Abstract] [Full Text] [Related]

  • 18. Transforming growth factor-alpha expression is enhanced in human mammary epithelial cells transformed by an activated c-Ha-ras protooncogene but not by the c-neu protooncogene, and overexpression of the transforming growth factor-alpha complementary DNA leads to transformation.
    Ciardiello F, McGeady ML, Kim N, Basolo F, Hynes N, Langton BC, Yokozaki H, Saeki T, Elliott JW, Masui H.
    Cell Growth Differ; 1990 Sep 01; 1(9):407-20. PubMed ID: 1981145
    [Abstract] [Full Text] [Related]

  • 19. Amplification of a novel v-erbB-related gene in a human mammary carcinoma.
    King CR, Kraus MH, Aaronson SA.
    Science; 1985 Sep 06; 229(4717):974-6. PubMed ID: 2992089
    [Abstract] [Full Text] [Related]

  • 20. Enhanced c-erbB-2/neu expression in human ovarian cancer cells correlates with more severe malignancy that can be suppressed by E1A.
    Yu D, Wolf JK, Scanlon M, Price JE, Hung MC.
    Cancer Res; 1993 Feb 15; 53(4):891-8. PubMed ID: 8094034
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.